Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 2881 AL 2895

Detecting TF-miRNA-gene network based modules for 5hmC and 5mC brain samples: a intra- and inter-species case-study between human and rhesus

Maulik U, Sen S, Mallik S, Bandyopadhyay S.

BMC Genet. 2018 Jan 22;19(1):9. doi: 10.1186/s12863-017-0574-7.

Profilin reduces aggregation and phase separation of huntingtin N-terminal fragments by preferentially binding to soluble monomers and oligomers

Posey AE, Ruff KM, Harmon TS, Crick SL, Li A, Diamond MI, Pappu RV.

J Biol Chem. 2018 Mar 9;293(10):3734-3746. doi: 10.1074/jbc.RA117.000357. Epub 2018 Jan 22.

Heat Shock Proteins and Autophagy Pathways in Neuroprotection: from Molecular Bases to Pharmacological Interventions

Penke B, Bogár F, Crul T, Sántha M, Tóth ME, Vígh L.

Int J Mol Sci. 2018 Jan 22;19(1):325. doi: 10.3390/ijms19010325.

The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms

Kang I, Chu CT, Kaufman BA.

FEBS Lett. 2018 Mar;592(5):793-811. doi: 10.1002/1873-3468.12989. Epub 2018 Feb 15.

Neurofilament light protein in blood predicts regional atrophy in Huntington disease

Johnson EB, Byrne LM, Gregory S, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RA, Zetterberg H, Tabrizi SJ, Scahill RI, Wild EJ; TRACK-HD Study Group.

Neurology. 2018 Feb 20;90(8):e717-e723. doi: 10.1212/WNL.0000000000005005. Epub 2018 Jan 24.

Review: Somatic mutations in neurodegeneration

Leija-Salazar M, Piette C, Proukakis C.

Neuropathol Appl Neurobiol. 2018 Apr;44(3):267-285. doi: 10.1111/nan.12465. Epub 2018 Feb 28.

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney MD, Sagare AP, Zlokovic BV.

Nat Rev Neurol. 2018 Mar;14(3):133-150. doi: 10.1038/nrneurol.2017.188. Epub 2018 Jan 29.

Potassium channel dysfunction in neurons and astrocytes in Huntington's disease

Zhang X, Wan JQ, Tong XP.

CNS Neurosci Ther. 2018 Apr;24(4):311-318. doi: 10.1111/cns.12804. Epub 2018 Jan 27.

Principles of diffusion kurtosis imaging and its role in early diagnosis of neurodegenerative disorders

Arab A, Wojna-Pelczar A, Khairnar A, Szabó N, Ruda-Kucerova J.

Brain Res Bull. 2018 May;139:91-98. doi: 10.1016/j.brainresbull.2018.01.015. Epub 2018 Jan 31.

A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea

Salpietro V, Perez-Dueñas B, Nakashima K, San Antonio-Arce V, Manole A, Efthymiou S, Vandrovcova J, Bettencourt C, Mencacci NE, Klein C, Kelly MP, Davies CH, Kimura H, Macaya A, Houlden H.

Mov Disord. 2018 Mar;33(3):482-488. doi: 10.1002/mds.27286. Epub 2018 Feb 2.

Tandem repeats mediating genetic plasticity in health and disease

Hannan AJ.

Nat Rev Genet. 2018 May;19(5):286-298. doi: 10.1038/nrg.2017.115. Epub 2018 Feb 5.

Subcortical neurodegeneration in chorea: Similarities and differences between chorea-acanthocytosis and Huntington's disease

Liu J, Heinsen H, Grinberg LT, Alho E, Amaro E Jr, Pasqualucci CA, Rüb U, den Dunnen W, Arzberger T, Schmitz C, Kiessling M, Bader B, Danek A.

Parkinsonism Relat Disord. 2018 Apr;49:54-59. doi: 10.1016/j.parkreldis.2018.01.009. Epub 2018 Jan 10.

Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism

Vercruysse P, Vieau D, Blum D, Petersén Å, Dupuis L.

Front Mol Neurosci. 2018 Jan 19;11:2. doi: 10.3389/fnmol.2018.00002. eCollection 2018.

Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments

Arnerić SP, Kern VD, Stephenson DT.

Biochem Pharmacol. 2018 May;151:291-306. doi: 10.1016/j.bcp.2018.01.043. Epub 2018 Feb 1.

Clinical Features of Huntington's Disease

Ghosh R, Tabrizi SJ.

Adv Exp Med Biol. 2018;1049:1-28. doi: 10.1007/978-3-319-71779-1_1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias